Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis-Reference-Cited by-同舟云学术

Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis

Published:2018-04 Issue:5 Volume:154 Page:1309-1319.e7
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Khera Rohan,Pandey Ambarish,Chandar Apoorva K.,Murad Mohammad H.,Prokop Larry J.,Neeland Ian J.,Berry Jarett D.,Camilleri Michael,Singh Siddharth^ORCID

Funder

National Institutes of Health

National Center for Advancing Translational Sciences

U.S. National Library of Medicine

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference56 articles.

1. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society;Jensen;Circulation,2014

2. Long-term weight loss after diet and exercise: a systematic review;Curioni;Int J Obes (Lond),2005

3. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis;Khera;JAMA,2016

4. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N Engl J Med,2016

5. Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial;Nissen;JAMA,2016

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing obesity management for women in an Indian obstetrics and gynecology setting: A consensus approach by the Indian Society of Assisted Reproduction (ISAR);Indian Journal of Obstetrics and Gynecology Research;2024-08-15

2. A novel structured, volume‐based, weight‐loss and health programme combined with respiratory muscle training helps reduce weight and cardiovascular risk in people with obesity;Diabetes, Obesity and Metabolism;2024-07-31

3. The Interplay between Obesity and Inflammation;Life;2024-07-08

4. Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction–associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease;Biomedicine & Pharmacotherapy;2024-06

5. A Review on Pharmacological and Non-Pharmacological Therapy for the treatment of Obesity with Cardiovascular Diseases;Research Journal of Pharmacology and Pharmacodynamics;2024-05-29